Two Sigma Investments, LP Bio N Tech Se Call Options Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$126.25 - $231.85 $5.73 Million - $10.5 Million
-45,400 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$216.64 - $362.52 $1.88 Million - $3.15 Million
8,700 Added 23.71%
45,400 $11.7 Million
Q3 2021

Nov 15, 2021
BUY
$205.93 - $447.23 $4.67 Million - $10.2 Million
22,700 Added 162.14%
36,700 $10 Million
Q2 2021

Aug 16, 2021
BUY
$113.32 - $241.49 $1.59 Million - $3.38 Million
14,000 New
14,000 $3.13 Million

Others Institutions Holding BNTX

# of Institutions
363
Shares Held
39.6M
Call Options Held
3.01M
Put Options Held
2.01M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.9B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email